Skin microvascular morphology and hemodynamics during treatment with veno-arterial extra-corporeal membrane oxygenation
T Wester, ZA Awan, TS Kvernebo… - Clinical …, 2014 - content.iospress.com
Objectives: To explore the potentials of microcirculatory assessments for predicting outcome
of patients treated with extra corporeal membrane oxygenation for cardiogenic shock …
of patients treated with extra corporeal membrane oxygenation for cardiogenic shock …
Clinical use of temporary percutaneous left ventricular assist devices
P Froesch, M Martinelli, P Meier, S Cook… - Catheterization and …, 2011 - Wiley Online Library
Background: Temporary percutaneous left ventricular assist devices (TPLVAD) can be
inserted and removed in awake patients. They substitute left ventricular function for a period …
inserted and removed in awake patients. They substitute left ventricular function for a period …
[HTML][HTML] Long-term left ventricle assist device (LVAD) therapy with rotary pumps
AE Fiane - Scandinavian Cardiovascular Journal, 2009 - Taylor & Francis
The consequences of the improvement in medical treatment (ie, betablockers, ACE
inhibitors, spironolactone) interventional cardiology, biventricular pacing and ICD are more …
inhibitors, spironolactone) interventional cardiology, biventricular pacing and ICD are more …
[PDF][PDF] Torjus Westera, b, Zaheer Ahmed Awana, b, Tobias Skylstad Kverneboa, c, Göran Salerudd and
K Kverneboa - researchgate.net
Objectives: To explore the potentials of microcirculatory assessments for predicting outcome
of patients treated with 12 extra corporeal membrane oxygenation for cardiogenic shock. 13 …
of patients treated with 12 extra corporeal membrane oxygenation for cardiogenic shock. 13 …
Venoarterielle Extrakorporale Membranoxygenierung bei kardialem und pulmonalem Organversagen
RP Zacher - 2013 - epub.uni-regensburg.de
Einleitung: ECMO gilt heute als anerkannte, artifizielle Kreislaufunterstützung, die auf einem
modifizierten kardio-pulmonalem Bypass-System basiert und ist heute va bei aggressivem …
modifizierten kardio-pulmonalem Bypass-System basiert und ist heute va bei aggressivem …
Acute heart failure syndromes: treatment, outcomes and pathophysiological aspects of inflammation and vascular function
SE Hermansen - 2012 - munin.uit.no
During the last three decades there has been extraordinary progress in the understanding of
the pathogenesis, and most importantly, the treatment of ischemic heart disease. This has …
the pathogenesis, and most importantly, the treatment of ischemic heart disease. This has …